Clinical studies recruiting near Kingston

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

Safety and Efficacy of Psilocybin-assisted Psychotherapy for Demoralization Syndrome in Patients Diagnosed With Advanced
Phase 1 · Queen's University · Gustavo Vazquez · NCT06818994 Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)
Phase 3 · Kingston Health Sciences Centre-Kingston General Hospital Si · Merck Sharp & Dohme LLC · NCT06393374 Real-world Experience Using Nemolizumab in the Treatment of Moderate-to-Severe Atopic Dermatitis in Adolescents & Adults
Phase N/A · Galderma Investigational Site 6393 · Galderma R&D · NCT06988605 Carotid Intraplaque Neovascularization Combined With Stress Echo
Phase N/A · The Kingston Heart Clinic · Dr. Amer Johri · NCT05416385 A Study to Evaluate the Long-term Safety and Tolerability of KarXT and KarX-EC for the Treatment of Schizophrenia and Au
Phase 3 · Local Institution - 0110 · Karuna Therapeutics, Inc., a Bristol Myers Squibb company · NCT07424404 Evaluating Omission of Granulocyte Colony-stimulating Factors in Breast Cancer Patients Receiving Paclitaxel Portion of
Phase 4 · Kingston Health Sciences Centre · Ottawa Hospital Research Institute · NCT05753618 Slowly Digestible Carbohydrates for GLP-1 Secretion
NA · Purdue University · NCT07572513 Canada-wide Implementation of a Virtual Sexual Health and Rehabilitation eClinic (SHAReClinic) for Prostate Cancer Patie
Phase N/A · Kingston Health Sciences Centre · University Health Network, Toronto · NCT06877598 Maximizing Nutrition Education to Meet Dietary and Food Security of Children and Parents
NA · Purdue University · NCT05196763 Magnesium Prophylaxis for the Prevention of New-Onset Atrial Fibrillation in Critically Ill Patients
Phase 4 · Kingston Health Sciences Centre · Dr. Stephanie Sibley · NCT05829317 EASi-KIDNEY™ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With Empagliflozin)
Phase 3 · Queen's University · Boehringer Ingelheim · NCT06531824 Response Variability to Exercise
NA · School of Kinesiology and Health Studies, Queen's University · Robert Ross, PhD · NCT05496751 Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Phase 2/Phase 3 · Kingston Health Sciences Centre · NRG Oncology · NCT05174169 Neurocognitive Outcomes for ICU Patients With Acute Kidney Injury
Phase N/A · Kingston Health Sciences Centre · Dr. Gordon Boyd · NCT04722939 Examining the Efficacy of a Digital Media Intervention to Increase Recruitment Rates
NA · Kingston Health Sciences Centre · IWK Health Centre · NCT07284329 A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung C
Phase 3 · Kingston Health Sciences Centre-Kingston General Hospital Si · Merck Sharp & Dohme LLC · NCT06623422 Fixed Duration vs Continuous Anti-CD38 Antibody Therapy Among Transplant Ineligible Older Adults With Newly-Diagnosed Mu
Phase 3 · Kingston Health Sciences Centre · Canadian Cancer Trials Group · NCT06182774 Liquid Biopsy for Early DiagNosis of Squamous Cell Carcinoma of the HeAd and NeCk rEgion
Phase N/A · Kingston Hospital Foundation Trust · Royal Marsden NHS Foundation Trust · NCT05645783 Falls Validation Study
Phase N/A · Kingston Health Sciences Centre · Dr. Kerstin de Wit · NCT07536906 A Study to Evaluate Finerenone on Clinical Efficacy and Safety in Patients With Heart Failure Who Are Intolerant or Not
Phase 3 · FIN-11024, Kingston, ON · Colorado Prevention Center · NCT06033950 A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancre
Phase 3 · Investigative Site CA008 · Incyte Corporation · NCT07522073 A Study of Brenipatide in Participants With Opioid Use Disorder
Phase 2 · Providence Care · Eli Lilly and Company · NCT07420283 Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and S
Phase 3 · Kingston Health Sciences Centre · Canadian Cancer Trials Group · NCT06592924 Safety, Tolerability, and Preliminary Efficacy of Psilocybin Oral Solution in Adults With Generalized Anxiety Disorder
Phase 2 · Kingston General Health Research Institute · Queen's University · NCT06969170 eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (CO
Phase 3 · GSK Investigational Site · GlaxoSmithKline · NCT07177339 A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed A
Phase 3 · Kingston Health Sciences Centre · Children's Oncology Group · NCT04293562 An Adjuvant Endocrine-based Therapy Study of Camizestrant (AZD9833) in ER+/HER2- Early Breast Cancer (CAMBRIA-2)
Phase 3 · Research Site · AstraZeneca · NCT05952557 Effects of Polyphenol Supplementation and Exercise on Physical Performance in Older Adults
NA · Queen's University School of Kinesiology & Health Studies · Dr. Chris McGlory, PhD · NCT07441343 A Clinical Trial of Adjuvant Intismeran (V940) With or Without Pembrolizumab Coformulated With Berahyaluronidase Alfa (M
Phase 3 · Kingston Health Sciences Centre-Kingston General Hospital Si · Merck Sharp & Dohme LLC · NCT07513376 Bronchodilators and Lung Mechanics During Exercise in COPD
Phase 4 · Respiratory Investigation Unit, Kingston Health Sciences Cen · Dr. J. Alberto Neder · NCT06825013

Look up another city

Look up another condition